Isaac Ro

Direktor/Vorstandsmitglied bei SEER, INC.

Vermögen: 76 670 $ am 31.05.2026

48 Jahre

100 Beziehungen

Finance

Health Technology

Health Services

Profil

Isaac Ro currently works at Haystack Oncology, Inc., as Executive Chairman, Seer, Inc. (California), as Director from 2025, Bioct Innovation Commons, as Director, and Catalio Capital Management LP, as Partner from 2023.
Mr. Ro also formerly worked at Leerink Partners LLC, as Director from 2004 to 2010, Independence Investments LLC, as Research Associate, Goldman Sachs & Co. LLC, as Analyst from 2013 to 2019, Aberdeen Content LLC, as Research Associate, Thrive Earlier Detection Corp., as Chief Financial Officer from 2019 to 2021, and GeneDx Holdings Corp., as Chief Financial Officer from 2021 to 2022.
Mr. Ro received his undergraduate degree in 2000 from Middlebury College.

Bekannte Unternehmensbeteiligungen

Unternehmen	Datum	Anzahl der Aktien	Bewertung	Datum der Bewertung
SEER, INC. CLASS A 0,07 %	02.09.2025	41.000 ( 0,07 % )	76 670 $	31.05.2026

Aktive Positionen von Isaac Ro

Unternehmen	Position	Beginn
SEER, INC.	Direktor/Vorstandsmitglied	02.09.2025
Bioct Innovation Commons	Direktor/Vorstandsmitglied	-
Haystack Oncology, Inc. Haystack Oncology, Inc. Medical/Nursing ServicesHealth Services Operates as an oncology care and MRD testing center	Vorsitzender	-
Catalio Capital Management LP Catalio Capital Management LP Investment ManagersFinance Catalio Capital invests in public and private companies located in the United States. The firm targets companies operating in the fields of life sciences developing next-generation drugs, devices and diagnostics, data, tools and innovative healthcare sectors. It provides financing for seed, early and later stage capital requirements and also makes co-investments.	Private Equity Investor	01.04.2023

Alle aktiven Positionen von Isaac Ro

Ehemalige bekannte Positionen von Isaac Ro

Unternehmen	Position	Ende
GENEDX HOLDINGS CORP.	Finanzdirektor/CFO	10.06.2022
Thrive Earlier Detection Corp. Thrive Earlier Detection Corp. Medical SpecialtiesHealth Technology Develops liquid biopsy test that is designed to detect cancers at early stages	Finanzdirektor/CFO	01.02.2021
Goldman Sachs & Co. LLC Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services	Analyst-Equity	01.06.2019
Leerink Partners LLC Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services	Analyst-Equity	31.05.2010
Independence Investments LLC Independence Investments LLC Investment ManagersFinance Independence follows a multi-dimensional investment process applying fundamental research and quantitative modeling to create return predictions. In fundamental research, analysts determine how economic and competitive forces are likely to shape the prospects for each of the companies in their investment universe. The analysts interview the management of these companies, as well as suppliers, customers, competitors and other industry experts. Quantitative research is then used to translate these fundamental insights into computer-based methods for stock selection. Independence's investment philosophy and process seeks to minimize style and sector biases.	Corporate Officer/Principal	-

Sehen Sie sich die Erfahrung von Isaac Ro im Detail an

Ausbildung von Isaac Ro

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Isaac Ro im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	11
Independence Investments LLC Independence Investments LLC Investment ManagersFinance Independence follows a multi-dimensional investment process applying fundamental research and quantitative modeling to create return predictions. In fundamental research, analysts determine how economic and competitive forces are likely to shape the prospects for each of the companies in their investment universe. The analysts interview the management of these companies, as well as suppliers, customers, competitors and other industry experts. Quantitative research is then used to translate these fundamental insights into computer-based methods for stock selection. Independence's investment philosophy and process seeks to minimize style and sector biases.	Finance
Goldman Sachs & Co. LLC Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services	Finance
Leerink Partners LLC Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services	Finance
Aberdeen Content LLC Aberdeen Content LLC Miscellaneous Commercial ServicesCommercial Services Provides fact based research services	Commercial Services
Middlebury College Middlebury College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Seer, Inc. (California) Seer, Inc. (California) BiotechnologyHealth Technology Provides research and development services for biotechnology	Health Technology
Thrive Earlier Detection Corp. Thrive Earlier Detection Corp. Medical SpecialtiesHealth Technology Develops liquid biopsy test that is designed to detect cancers at early stages	Health Technology
Catalio Capital Management LP Catalio Capital Management LP Investment ManagersFinance Catalio Capital invests in public and private companies located in the United States. The firm targets companies operating in the fields of life sciences developing next-generation drugs, devices and diagnostics, data, tools and innovative healthcare sectors. It provides financing for seed, early and later stage capital requirements and also makes co-investments.	Finance
GeneDx Holdings Corp. GeneDx Holdings Corp. Medical/Nursing ServicesHealth Services Provides diagnostic genetic testing services	Health Services
Bioct Innovation Commons	Finance
Haystack Oncology, Inc. Haystack Oncology, Inc. Medical/Nursing ServicesHealth Services Operates as an oncology care and MRD testing center	Health Services